Addus HomeCare (ADUS)

• Market cap: $2.43B
• 1 day: 0.41%
• 5 days: 6.95%
• 1 month: 2.40%
• 3 months: 0.65%
• 6 months: 9.68%
• Year to date: 7.73%
• 1 year: 49.24%
• 5 years: 37.44%
• 10 years: 506.30%
• Sector: Healthcare
• Industry: Home Health Care Services

About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Employees: 34,846

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

225% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $918K

100% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

38% more repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 89

10% more capital invested

Capital invested by funds: $2.14B [Q2] → $2.35B (+$217M) [Q3]

8% more funds holding

Funds holding: 284 [Q2] → 306 (+22) [Q3]

14.68% less ownership

Funds ownership: 112.56% [Q2] → 97.88% (-14.68%) [Q3]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $136 2% upside
• Avg. target: $143 6% upside
• High target: $150 12% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

JMP Securities Constantine Davides 26% 1-year accuracy 7 / 27 met price target	12% upside $150	Market Outperform Initiated	16 Dec 2024
RBC Capital Ben Hendrix 29% 1-year accuracy 20 / 70 met price target	2% upside $136	Outperform Reiterated	14 Nov 2024
Stephens & Co. Scott Fidel 56% 1-year accuracy 22 / 39 met price target	8% upside $145	Overweight Maintained	6 Nov 2024
Macquarie Tao Qiu 38% 1-year accuracy 6 / 16 met price target	4% upside $139	Outperform Maintained	4 Nov 2024